等待開盤 09-20 09:30:00 美东时间
-2.810
-4.51%
Shares of Halozyme Therapeutics (NASDAQ:HALO) trended lower on Thursday after J.P. Morgan downgraded the developer of Enhanze drug delivery technology to neutral from overweight, arguing that the stoc...
09-19 22:11
Halozyme Therapeutics Inc : JP Morgan Cuts to Neutral From Overweight
09-19 12:34
Halozyme Therapeutics Inc : Benchmark Raises Target Price to $75 From $60
09-16 18:34
In the ever-evolving and intensely competitive business landscape, conducting a...
08-27 23:00
As of Aug 26, 2024, two stocks in the health care sector could be flashing a re...
08-26 19:53
Halozyme Therapeutics's (NYSE:HALO) short percent of float has risen 3.46% sinc...
08-20 21:16
DURHAM, NC / ACCESSWIRE / August 15, 2024 / 374Water Inc. (NASDAQ:SCWO), a glob...
08-15 20:00
Howard Marks put it nicely when he said that, rather than worrying about share ...
08-08 22:06
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-08 05:12
Halozyme Therapeutics Inc : Leerink Partners Raises Target Price to $56 From $53
08-07 18:03